Cargando…
Platelet Activation and Platelet–Leukocyte Aggregates in Type I Diabetes Mellitus
Hyperglycemia alone may not explain the increased risk of cardiovascular diseases (CVDs) in patients with type 1 diabetes (T1D) compared with type 2. This study emphases on the evaluation of some platelet activity markers in patients with T1D, with relevance to some metabolic disorders as hyperlipid...
Autores principales: | Zahran, Asmaa M., El-Badawy, Omnia, Mohamad, Ismail L., Tamer, Deiaaeldin M., Abdel-Aziz, Safwat M., Elsayh, Khalid I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714843/ https://www.ncbi.nlm.nih.gov/pubmed/30309255 http://dx.doi.org/10.1177/1076029618805861 |
Ejemplares similares
-
Circulating Endothelial Cells, Circulating Endothelial Progenitor Cells, and
Circulating Microparticles in Type 1 Diabetes Mellitus
por: Zahran, Asmaa M., et al.
Publicado: (2019) -
Upregulation of CD146 in Pediatric B-Cell Acute Lymphocytic Leukemia and Its Implications on Treatment Outcomes
por: Zahran, Asmaa M., et al.
Publicado: (2020) -
Circulating microparticles and activated platelets as novel prognostic biomarkers in COVID-19; relation to cancer
por: Zahran, Asmaa M., et al.
Publicado: (2021) -
Measuring and interpreting platelet-leukocyte aggregates
por: Finsterbusch, Michaela, et al.
Publicado: (2018) -
Could the Crosstalk Between Myeloid-Derived-Suppressor Cells and Regulatory T Cells Have a Role in Beta-Thalassemia?
por: Zahran, Asmaa M., et al.
Publicado: (2023)